Acute kidney injury following transcatheter aortic valve implantation: Incidence, predictors and clinical outcome

International Journal of Cardiology

Volumn 168, Issue 2, 2013, Pages 1034-1040

  Saia, Francesco ^a   Ciuca, Cristina ^a   Taglieri, Nevio ^a   Marrozzini, Cinzia ^a   Savini, Carlo ^a   Bordoni, Barbara ^a   Dall'Ara, Gianni ^a   Moretti, Carolina ^a   Pilato, Emanuele ^a   Martn Suàrez, Sofia ^a   Petridis, Francesco Dimitri ^a   Di Bartolomeo, Roberto ^a   Branzi, Angelo ^a   Marzocchi, Antonio ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Acute kidney injury; Aortic valve stenosis; Outcome; Transcatheter aortic valve implantation

Indexed keywords

ACUTE KIDNEY FAILURE; AGE DISTRIBUTION; AGED; AORTA VALVE STENOSIS; ARTICLE; CLINICAL ASSESSMENT TOOL; COMORBIDITY; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE REGISTRY; EUROSCORE; FEMALE; GLOMERULUS FILTRATION RATE; HEART VALVE PROSTHESIS; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; STS SCORE; SURVIVAL RATE; SURVIVAL TIME; TRANSCATHETER AORTIC VALVE IMPLANTATION; VASCULAR ACCESS;

ACUTE KIDNEY INJURY; AORTIC VALVE STENOSIS; OUTCOME; TRANSCATHETER AORTIC VALVE IMPLANTATION;

ACUTE KIDNEY INJURY; AGED; AGED, 80 AND OVER; CARDIAC CATHETERIZATION; FEMALE; FOLLOW-UP STUDIES; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; INCIDENCE; MALE; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; REGISTRIES; TREATMENT OUTCOME;

EID: 84885292264     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2012.10.029     Document Type: Article

References (32)

1. Leon MB, Smith CR, Mack M, et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med 2010;363: 1597-607.
2. Piazza N, Grube E, Gerckens U, et al. Procedural and 30-day outcomes following transcatheter aortic valve implantation using the third generation (18 Fr) corevalve revalving system: results from the multicentre, expanded evaluation registry 1-year following CE mark approval. EuroIntervention 2008;4:242-9.
3. Webb JG, Pasupati S, Humphries K, et al. Percutaneous transarterial aortic valve replacement in selected high-risk patients with aortic stenosis. Circulation 2007;116: 755-63.
4. Smith CR, Leon MB, Mack MJ, et al. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med 2011;364:2187-98.
5. Masson JB, Kovac J, Schuler G, et al. Transcatheter aortic valve implantation: review of the nature, management, and avoidance of procedural complications. JACC Cardiovasc Interv 2009;2:811-20.
6. Saia F, Bordoni B, Marrozzini C, et al. Incidence, prognostic value and management of vascular complications with transfemoral transcatheter aortic valve implantation. Future Cardiol 2011;7:321-31.
7. Kodali SK, O'NeillWW,Moses JW, et al. Early and late (one year) outcomes following transcatheter aortic valve implantation in patients with severe aortic stenosis (from the United States REVIVAL Trial). Am J Cardiol 2011;107:1058-64.
8. Rosner MH, Okusa MD. Acute kidney injury associated with cardiac surgery. Clin J Am Soc Nephrol 2006;1:19-32.
9. Nuis RJ, Van Mieghem NM, Tzikas A, et al. Frequency, determinants, and prognostic effects of acute kidney injury and red blood cell transfusion in patients undergoing transcatheter aortic valve implantation. Catheter Cardiovasc Interv 2011;77:881-9.
10. Aregger F, Wenaweser P, Hellige GJ, et al. Risk of acute kidney injury in patients with severe aortic valve stenosis undergoing transcatheter valve replacement. Nephrol Dial Transplant 2009;24:2175-9.
11. Bagur R, Webb JG, Nietlispach F, et al. Acute kidney injury following transcatheter aortic valve implantation: predictive factors, prognostic value, and comparison with surgical aortic valve replacement. Eur Heart J 2009;31:865-74.
12. Elhmidi T, Bleiziffer S, Piazza N, et al. Incidence and predictors of acute kidney injury in patients undergoing transcatheter aortic valve implantation. Am Heart J 2011;161: 735-9.
13. Leon MB, Piazza N, Nikolsky E, et al. Standardized endpoint definitions for transcatheter aortic valve implantation clinical trials: a consensus report from the Valve Academic Research Consortium. Eur Heart J 2011;32:105-17.
14. Saia F, Marrozzini C, Dall'Ara G, et al. How many patients with severe symptomatic aortic stenosis excluded for cardiac surgery are eligible for transcatheter heart valve implantation? J Cardiovasc Med (Hagerstown) 2010;11:727-32.
15. Roques F, Nashef SA, Michel P, et al. Risk factors and outcome in European cardiac surgery: analysis of the EuroSCORE multinational database of 19030 patients. Eur J Cardiothorac Surg 1999;15:816-22.
16. Dewey TM, Brown D, Ryan WH, Herbert MA, Prince SL, Mack MJ. Reliability of risk algorithms in predicting early and late operative outcomes in high-risk patients undergoing aortic valve replacement. J Thorac Cardiovasc Surg 2008;135:180-7.
17. Nkomo VT, Gardin JM, Skelton TN, Gottdiener JS, Scott CG, Enriquez-Sarano M. Burden of valvular heart diseases: a population-based study. Lancet 2006;368: 1005-11.
18. Ussia GP, Scarabelli M, Mule M, et al. Postprocedural management of patients after transcatheter aortic valve implantation procedure with self-expanding bioprosthesis. Catheter Cardiovasc Interv 2010;76:757-66.
19. Sinning JM, Ghanem A, Steinhauser H, et al. Renal function as predictor of mortality in patients after percutaneous transcatheter aortic valve implantation. JACC Cardiovasc Interv 2010;3:1141-9.
20. Thomas M, Schymik G, Walther T, et al. Thirty-day results of the SAPIEN aortic Bioprosthesis European Outcome (SOURCE) Registry: a European registry of transcatheter aortic valve implantation using the Edwards SAPIEN valve. Circulation 2010;122:62-9.
21. Rajani R, Haworth P, Hildick-Smith D. The incidence of nephropathy in patients undergoing transcatheter aortic valve implantation. Catheter Cardiovasc Interv 2009;74:662-3.
22. Bellomo R, Kellum JA, Ronco C. Defining and classifying acute renal failure: from advocacy to consensus and validation of the RIFLE criteria. Intensive Care Med 2007;33:409-13.
23. Ewe SH,Delgado V,Ng AC, et al.Outcomes after transcatheter aortic valve implantation: transfemoral versus transapical approach. Ann Thorac Surg 2011;92:1244-51.
24. Karkouti K, Wijeysundera DN, Yau TM, et al. Acute kidney injury after cardiac surgery: focus on modifiable risk factors. Circulation 2009;119:495-502.
25. Tamburino C, Capodanno D, Ramondo A, et al. Incidence and predictors of early and late mortality after transcatheter aortic valve implantation in 663 patients with severe aortic stenosis. Circulation 2011;123:299-308.
26. Rodes-Cabau J, Webb JG, Cheung A, et al. Transcatheter aortic valve implantation for the treatment of severe symptomatic aortic stenosis in patients at very high or prohibitive surgical risk: acute and late outcomes of the multicenter Canadian experience. J Am Coll Cardiol 2010;55:1080-90.
27. Schrier RW. Role of diminished renal function in cardiovascular mortality: marker or pathogenetic factor? J Am Coll Cardiol 2006;47:1-8.
28. Lassnigg A, Schmidlin D, Mouhieddine M, et al. Minimal changes of serum creatinine predict prognosis in patients after cardiothoracic surgery: a prospective cohort study. J Am Soc Nephrol 2004;15:1597-605.
29. Loef BG, Epema AH, Smilde TD, et al. Immediate postoperative renal function deterioration in cardiac surgical patients predicts in-hospitalmortality and long-termsurvival. J Am Soc Nephrol 2005;16:195-200.
30. Kolli H, Rajagopalam S, Patel N, et al. Mild acute kidney injury is associated with increasedmortality after cardiac surgery in patientswith eGFRb60 mL/min/1.73 m(2). Ren Fail 2010;32:1066-72.
31. Caixeta A, Mehran R. Evidence-based management of patients undergoing PCI: contrast-induced acute kidney injury. Catheter Cardiovasc Interv 2010;75(Suppl. 1): S15-20.
32. Patel NN, Rogers CA, Angelini GD, et al. Pharmacological therapies for the prevention of acute kidney injury following cardiac surgery: a systematic review. Heart Fail Rev 2011;16:553-67.